NF1 and glioblastoma: While Ras genes are infrequently mutated in human GBM (∼2%; Prior et al., 2020), the RAS/MAPK pathway is frequently activated via mutational loss of the NF1 tumor suppressor gene (14%–23% of GBM; Philpott et al., 2017).